SeraCare Acquired by LGC
Manufacturer of quality control materials SeraCare Life Sciences has been acquired by LGC, an international life sciences measurement and testing company, strengthening LGC’s position in the clinical quality control tools market.
SeraCare provides tools and materials for infectious disease testing in the clinical next-generation sequencing (NGS) market through its oncology, NIPT and inherited disease testing products.
This follows a number of acquisitions LGC has made in the last few years, including Berry and Associates, Lucigen and Douglas Scientific. LGC said that SeraCare’s Seraseq clinical genomics tools complement its component offerings to the NGS market, and expand LGC’s calibration verification materials and proficiency testing offerings.